NSE: SRF | BSE: 503806

Falling Comet

Download real time

2614.90 31.30 (1.21%)

New 52W Low in past week

386.1K NSE+BSE Volume

NSE 25 Feb, 2026 3:31 PM (IST)

77,512.1

Market Cap

Market Runner Up

Beta 1Year

High Volatility

Analyst Underweight

Morgan Stanley retains an 'Underweight' rating on SRF; warns of refrigerant price pressure See details

SRF Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SRF, BSE:503806 SRF Ltd.

Search Inside the pdf :

SRF Ltd.

04 Feb 2026

2614.90

1.21%

*over or under performance to benchmark index SRF Limited manufactures and sells textiles, chemicals, films, and polymers through four business segments: Technical, Chemicals, Packaging, and Others, with diverse...

Number of FII/FPI investors decreased from 679 to 666 in Dec 2025 qtr

SRF Ltd.

22 Jan 2026

2614.90

1.21%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q3FY26- Chemicals Business drives growth- Revenues grew 6% YoY to 3,611.5 crore driven by the Chemicals business (49% of the revenues) which reported a growth of 22% YoY to 1,825 crore. Meanwhile performance films (36% of revenues) declined by 3% YoY to 1,342 crore and Technical Textiles (12% of revenues) reported a decline of 11% YoY for the third consecutive quarter to 453 crore. Consolidated EBITDA stood at 780 crore, up 26% YoY, translating to margins of 21%, up ~330 bps YoY driven by the chemical business EBIT which stood at 27%, up ~300 bps YoY....

SRF Ltd. has an average target of 3405.00 from 9 brokers.

SRF Ltd.

21 Jan 2026

2614.90

1.21%

SRF Q3FY26 Result Review

Buy: SRF Ltd.

IDBI Capital

SRF delivered results which were only marginally below our estimates. While Revenue grew by 6% YoY, EBITDA and Adjusted PAT grew by impressive rates of 26% and 86%. The chemicals business continued to exhibit strong growth owing to higher HFC pricing and placement of higher volumes in domestic and export markets. Although some orders have been deferred on the agro side, the management expects to recoup majority of the same in Q4FY26. Pent up purchase orders are expected to convert in Q4FY26 leading to a robust quarter, a trend which was seen in Q4FY25 as well. Specialty Chemicals Business grew on...

SRF Ltd. is trading below all available SMAs

SRF Ltd.

21 Jan 2026

2614.90

1.21%

BP Equities Q3FY26 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

...

Number of FII/FPI investors decreased from 679 to 666 in Dec 2025 qtr

SRF Ltd.

20 Jan 2026

2614.90

1.21%

Strong performance continues in Chemical business

Buy: SRF Ltd.

Target

Motilal Oswal

SRF delivered a healthy performance in 3QFY26 as EBIT surged 25% YoY, fueled by a strong 36% YoY jump in chemical segment EBIT, despite persistent global headwinds.

SRF Ltd. is trading below all available SMAs

SRF Ltd.

08 Dec 2025

2614.90

1.21%

Upcycle across chemicals businesses; upside risk to consensus EPS

Buy: SRF Ltd.

Recommendation Target

ICICI Securities Limited

We remain sanguine on SRF’s chemicals business, with performance potentially improving across ref-gas, specialty chemicals and fluoropolymers. Higher volumes and sustained prices present ~15–20% upside risk in ref-gas business’ base-case revenues vs. a more plausible assessment.

Number of FII/FPI investors decreased from 679 to 666 in Dec 2025 qtr

SRF Ltd.

31 Oct 2025

2614.90

1.21%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q2FY26 Chemicals Business drives growth- Revenues grew 6% YoY to 3,534.5 crore driven by the Chemicals business (46% of the revenues) which reported a growth of 23% YoY to 1,667 crore. While technical textiles (13% of the revenue) and Packaging films (39% of revenues) reported a decline of 11% and 1% to 474.3 crore and 1,408 crore respectively. Consolidated EBITDA stood at 774.2 crore, up 44% YoY, translating to margins of 21.3%, up ~560 bps YoY driven by the Chemical business (EBIT) which stood at 29%, up ~1100 bps YoY. Moreover, PAT for...

SRF Ltd. is trading below all available SMAs

SRF Ltd.

29 Oct 2025

2614.90

1.21%

BP Equities Q2FY26 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

...

SRF Ltd. is trading below all available SMAs

SRF Ltd.

29 Oct 2025

2614.90

1.21%

SRF: Q2FY26 Result Review

Buy: SRF Ltd.

Recommendation Target

IDBI Capital

SRF delivered results in line with our expectations primarily owing to healthy performance in specialty chemicals and higher pricing of refrigerant gases. Higher volumes especially in HFCs also contributed to the growth. While Revenue grew by 6% YoY, EBITDA and PAT grew by impressive rates of 44% and 93% respectively. The chemicals business registered strong revenue growth of 23% YoY along with ~1080 bps of YoY margin improvement to 28.9%. Although some orders have been deferred on the agro side, we expect SRF to recoup the same in H2FY26. The Fluorochemicals part of the business was elevated by...

SRF Ltd. has an average target of 3405.00 from 9 brokers.

SRF Ltd.

28 Oct 2025

2614.90

1.21%

Chemical and PFF continue to support operating performance

Buy: SRF Ltd.

Motilal Oswal

SRF delivered a strong 2QFY26, with EBIT surging 55% YoY, fueled by a robust 96%/44% YoY jump in the chemicals/performance films & foil (PFF) businesses, despite ongoing global headwinds.

SRF Ltd. has an average target of 3405.00 from 9 brokers.

Is SRF Ltd. worth buying?

428 Votes:

Buy 74.53%

Sell 15.42%

Hold 10.05%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf